Ana Maria Ortega‐Prieto

Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia

Luca Braga, Hashim Ali, Ilaria Secco et al. · Nature · 2021 · 435 citations · Full text

Medicine, Mechanism Of Action, Pharmacotherapy +4

3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection

Ana Maria Ortega‐Prieto, Jessica Katy Skelton, Sun Nyunt Wai et al. · Nature Communications · 2018 · 220 citations · Full text

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern

Liane Dupont, Luke B. Snell, Carl Graham et al. · Nature Microbiology · 2021 · 116 citations · Full text

Extinction of Hepatitis C Virus by Ribavirin in Hepatoma Cells Involves Lethal Mutagenesis

Ana Maria Ortega‐Prieto, Julie Sheldon, Ana Grande-Pérez et al. · PLoS ONE · 2013 · 70 citations · Full text

Viral Replication, Hepatitis C Virus, Pathology +18

Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry

Michela Mazzon, Ana Maria Ortega‐Prieto, Douglas Imrie et al. · Viruses · 2019 · 70 citations · Full text

Virus Epidemics, Antiviral Agents, Medicine +11